Systematic, network-based characterization of therapeutic target inhibitors
暂无分享,去创建一个
Andrea Califano | Mariano J. Alvarez | Alexander Lachmann | Brygida C. Bisikirska | Yao Shen | Sergey Pampou | Ronald Realubit | Charles Karan | Jorida Coku | A. Califano | B. Bisikirska | M. Alvarez | Alexander Lachmann | Yao Shen | Ronald B. Realubit | Charles Karan | Sergey Pampou | Jorida Coku
[1] Mingming Jia,et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer , 2010, Nucleic Acids Res..
[2] Byung Min Chung,et al. Aberrant trafficking of NSCLC-associated EGFR mutants through the endocytic recycling pathway promotes interaction with Src@ , 2009, BMC Cell Biology.
[3] Igor Chourpa,et al. Differential Subcellular Distribution of Mitoxantrone in Relation to Chemosensitization in Two Human Breast Cancer Cell Lines , 2007, Drug Metabolism and Disposition.
[4] Hua Yu,et al. STATs in cancer inflammation and immunity: a leading role for STAT3 , 2009, Nature Reviews Cancer.
[5] Andrea Califano,et al. Integrated biochemical and computational approach identifies BCL6 direct target genes controlling multiple pathways in normal germinal center B cells. , 2008, Blood.
[6] J. Uhm. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2009 .
[7] Olov Sterner,et al. Galiellalactone is a novel therapeutic candidate against hormone‐refractory prostate cancer expressing activated Stat3 , 2008, The Prostate.
[8] David A. Frank,et al. Targeting transcription factors: promising new strategies for cancer therapy , 2013, Current opinion in oncology.
[9] Mariano J. Alvarez,et al. The recurrent architecture of tumour initiation, progression and drug sensitivity , 2016, Nature Reviews Cancer.
[10] J. Bajorath,et al. Docking and scoring in virtual screening for drug discovery: methods and applications , 2004, Nature Reviews Drug Discovery.
[11] Angela N Koehler,et al. A complex task? Direct modulation of transcription factors with small molecules. , 2010, Current opinion in chemical biology.
[12] Roland Schmitz,et al. Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma , 2015, Nature Medicine.
[13] Osborne Ck,et al. Tamoxifen in the Treatment of Breast Cancer , 1998 .
[14] Qiang He,et al. Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway. , 2010, ACS medicinal chemistry letters.
[15] María Rodríguez Martínez,et al. Elucidating Compound Mechanism of Action by Network Perturbation Analysis Graphical , 2015 .
[16] Mariano J. Alvarez,et al. Network-based inference of protein activity helps functionalize the genetic landscape of cancer , 2016, Nature Genetics.
[17] J. Bajorath,et al. Polypharmacology: challenges and opportunities in drug discovery. , 2014, Journal of medicinal chemistry.
[18] Gautam Sethi,et al. Targeting PPARγ Signaling Cascade for the Prevention and Treatment of Prostate Cancer , 2012, PPAR research.
[19] Wei Keat Lim,et al. Master Regulators Used As Breast Cancer Metastasis Classifier , 2008, Pacific Symposium on Biocomputing.
[20] Chris Wiggins,et al. ARACNE: An Algorithm for the Reconstruction of Gene Regulatory Networks in a Mammalian Cellular Context , 2004, BMC Bioinformatics.
[21] K. Sneppen,et al. Specificity and Stability in Topology of Protein Networks , 2002, Science.
[22] Theonie Anastassiadis,et al. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity , 2011, Nature biotechnology.
[23] S. Collins,et al. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[24] Bianca Sperl,et al. Stattic: a small-molecule inhibitor of STAT3 activation and dimerization. , 2006, Chemistry & biology.
[25] R M Mader,et al. Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex , 2013, British Journal of Cancer.
[26] L. Penn,et al. Reflecting on 25 years with MYC , 2008, Nature Reviews Cancer.
[27] J. Uhm,et al. The transcriptional network for mesenchymal transformation of brain tumours , 2010 .
[28] Michael J. Keiser,et al. Predicting new molecular targets for known drugs , 2009, Nature.
[29] N. Jing,et al. Targeting Stat3 in cancer therapy. , 2005, Anti-cancer drugs.
[30] Sean R. Davis,et al. NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..
[31] Mariano J. Alvarez,et al. Cross-species regulatory network analysis identifies a synergistic interaction between FOXM1 and CENPF that drives prostate cancer malignancy. , 2014, Cancer cell.
[32] Nobuhiko Takamatsu,et al. The HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin modulates radiosensitivity by downregulating serine/threonine kinase 38 via Sp1 inhibition. , 2013, European journal of cancer.
[33] Paul A Clemons,et al. The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease , 2006, Science.
[34] R. Shoemaker. The NCI60 human tumour cell line anticancer drug screen , 2006, Nature Reviews Cancer.
[35] Avi Ma'ayan,et al. ChEA: transcription factor regulation inferred from integrating genome-wide ChIP-X experiments , 2010, Bioinform..
[36] Mariano J. Alvarez,et al. A human B-cell interactome identifies MYB and FOXM1 as master regulators of proliferation in germinal centers , 2010, Molecular systems biology.
[37] Davide Heller,et al. STRING v10: protein–protein interaction networks, integrated over the tree of life , 2014, Nucleic Acids Res..
[38] Alexander Tropsha,et al. Best Practices for QSAR Model Development, Validation, and Exploitation , 2010, Molecular informatics.
[39] D B Evans,et al. Sequential changes in gene expression profiles in breast cancers during treatment with the aromatase inhibitor, letrozole , 2010, The Pharmacogenomics Journal.
[40] David S. Wishart,et al. DrugBank 4.0: shedding new light on drug metabolism , 2013, Nucleic Acids Res..
[41] W. Huber,et al. Differential expression analysis for sequence count data , 2010 .
[42] Joshua C. Gilbert,et al. An Interactive Resource to Identify Cancer Genetic and Lineage Dependencies Targeted by Small Molecules , 2013, Cell.
[43] A. Butte,et al. Leveraging models of cell regulation and GWAS data in integrative network-based association studies , 2012, Nature Genetics.
[44] A. Califano,et al. STK38 is a critical upstream regulator of MYC’s oncogenic activity in human B-cell lymphoma , 2013, Oncogene.
[45] Andrew D. Rouillard,et al. LINCS Canvas Browser: interactive web app to query, browse and interrogate LINCS L1000 gene expression signatures , 2014, Nucleic Acids Res..
[46] C. Howe,et al. The STAT3 beacon: IL-6 recurrently activates STAT 3 from endosomal structures. , 2011, Experimental cell research.
[47] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[48] Michael H. Tomasson,et al. Neoplasia Driven by Mutant c-KIT Is Mediated by Intracellular, Not Plasma Membrane, Receptor Signaling , 2006, Molecular and Cellular Biology.